Home > Qtrly Results > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Quarterly Results Analysis [Sep2026]

STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Quarterly Results

Consolidated Sep2026
UnAudited
Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Revenues ₹1,430 Cr ₹1,265 Cr ₹1,323 Cr ₹1,195 Cr ₹1,221 Cr ₹1,120 Cr ₹1,190 Cr ₹1,154 Cr
Expenses ₹1,179 Cr ₹1,036 Cr ₹1,084 Cr ₹959 Cr ₹989 Cr ₹902 Cr ₹973 Cr ₹943 Cr
Operating Income ₹251 Cr ₹230 Cr ₹240 Cr ₹236 Cr ₹232 Cr ₹218 Cr ₹218 Cr ₹210 Cr
Other Income ₹4 Cr ₹5 Cr ₹8 Cr ₹107 Cr ₹27 Cr ₹9 Cr ₹12 Cr ₹6 Cr
Interest ₹47 Cr ₹41 Cr ₹42 Cr ₹43 Cr ₹46 Cr ₹47 Cr ₹50 Cr ₹52 Cr
Depreciation ₹57 Cr ₹56 Cr ₹53 Cr ₹51 Cr ₹50 Cr ₹49 Cr ₹49 Cr ₹48 Cr
Profit Before Tax ₹150 Cr ₹201 Cr ₹147 Cr ₹246 Cr ₹154 Cr ₹122 Cr ₹103 Cr ₹113 Cr
Profit After Tax ₹133 Cr ₹167 Cr ₹128 Cr ₹208 Cr ₹133 Cr ₹105 Cr ₹82 Cr ₹89 Cr
EPS ₹14.19 ₹17.03 ₹13.77 ₹21.93 ₹13.84 ₹10.81 ₹8.92 ₹9.54
Industry Peers & Returns1W1M1Y
STRIDES PHARMA SCIENCE -2.1% -3.3% 2.6%
SUN PHARMACEUTICAL INDUSTRIES 1% 7.5% 7.9%
DIVIS LABORATORIES 0.8% 22.8% 71.4%
TORRENT PHARMACEUTICALS 0.2% 1.9% 20.9%
CIPLA 1.5% 6.4% -7.8%
DR REDDYS LABORATORIES 0.8% 12.2% 12.3%
MANKIND PHARMA 1.3% 16.8% 17.2%
LUPIN 1.9% 4.3% -2.6%
ZYDUS LIFESCIENCES 0.5% 5.3% 28.4%

STRIDES PHARMA SCIENCE Quarterly Revenues

Revenues
Q-o-Q

12.99 %

Y-o-Y

17.11 %

Quarters Revenues % Change
Sep2026 ₹1,430 Cr
12.99
Jun2026 ₹1,265 Cr
-4.39
Mar2026 ₹1,323 Cr
10.78
Dec2025 ₹1,195 Cr
-2.14
Sep2025 ₹1,221 Cr
9.03
Jun2025 ₹1,120 Cr
-5.94
Mar2025 ₹1,190 Cr
3.18
Dec2024 ₹1,154 Cr -

STRIDES PHARMA SCIENCE Quarterly Operating Profit

Operating Profit
Q-o-Q

9.20 %

Y-o-Y

8.35 %

Quarters Operating Profit % Change
Sep2026 ₹251 Cr
9.20
Jun2026 ₹230 Cr
-4.14
Mar2026 ₹240 Cr
1.59
Dec2025 ₹236 Cr
1.89
Sep2025 ₹232 Cr
6.19
Jun2025 ₹218 Cr
0.09
Mar2025 ₹218 Cr
3.59
Dec2024 ₹210 Cr -
Operating Margins
Q-o-Q

-3.36 %

Y-o-Y

-7.49 %

Quarters Operating Margin% % Change
Sep2026 17.55%
-3.36
Jun2026 18.16%
0.28
Mar2026 18.11%
-8.30
Dec2025 19.75%
4.11
Sep2025 18.97%
-2.62
Jun2025 19.48%
6.45
Mar2025 18.3%
0.38
Dec2024 18.23% -

STRIDES PHARMA SCIENCE Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-20.12 %

Y-o-Y

0.49 %

Quarters Profit After Tax % Change
Sep2026 ₹133 Cr
-20.12
Jun2026 ₹167 Cr
30.47
Mar2026 ₹128 Cr
-38.59
Dec2025 ₹208 Cr
57.01
Sep2025 ₹133 Cr
25.67
Jun2025 ₹105 Cr
27.89
Mar2025 ₹82 Cr
-7.41
Dec2024 ₹89 Cr -
PAT Margins
Q-o-Q

-29.29 %

Y-o-Y

-14.18 %

Quarters PAT Margin(%) % Change
Sep2026 9.32 %
-29.29
Jun2026 13.18 %
36.44
Mar2026 9.66 %
-44.55
Dec2025 17.42 %
60.41
Sep2025 10.86 %
15.29
Jun2025 9.42 %
35.93
Mar2025 6.93 %
-10.23
Dec2024 7.72 % -

STRIDES PHARMA SCIENCE Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-16.68 %

Y-o-Y

2.53 %

Quarters EPS % Change
Sep2026 ₹14.19
-16.68
Jun2026 ₹17.03
23.67
Mar2026 ₹13.77
-37.21
Dec2025 ₹21.93
58.45
Sep2025 ₹13.84
28.03
Jun2025 ₹10.81
21.19
Mar2025 ₹8.92
-6.50
Dec2024 ₹9.54 -

You may also like the below Video Courses